APA

Buonomo A. R., Maraolo A. E., Scotto R., Foggia M., Zappulo E., Congera P., Parente S. & Gentile I. (20200402). Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience. : Infection.

Chicago

Buonomo A R, Maraolo A E, Scotto R, Foggia M, Zappulo E, Congera P, Parente S and Gentile I. 20200402. Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience. : Infection.

Harvard

Buonomo A. R., Maraolo A. E., Scotto R., Foggia M., Zappulo E., Congera P., Parente S. and Gentile I. (20200402). Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience. : Infection.

MLA

Buonomo A R, Maraolo A E, Scotto R, Foggia M, Zappulo E, Congera P, Parente S and Gentile I. Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience. : Infection. 20200402.